1 – 10 of 23
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Forty years of successful national research collaboration in liver disease–the Swedish experience
(
- Contribution to journal › Scientific review
- 2023
-
Mark
Impact on follow-up strategies in patients with primary sclerosing cholangitis
(
- Contribution to journal › Article
- 2022
-
Mark
Development of a prognostic MRCP score (DiStrict) for patients with large-duct primary sclerosing cholangitis
(
- Contribution to journal › Article
-
Mark
Development of a novel MRCP-score for patients with primary sclerosing cholangitis, and assessment of agreement and prognostic value
(
- Contribution to journal › Published meeting abstract
- 2020
-
Mark
Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis
(
- Contribution to journal › Article
- 2017
-
Mark
Epidemiology and causes of death in a Swedish cohort of patients with autoimmune hepatitis
(
- Contribution to journal › Article
-
Mark
Histological improvement of liver fibrosis in well-treated patients with autoimmune hepatitis
(
- Contribution to journal › Article
-
Mark
Composition and functionality of the intrahepatic innate lymphoid cell-compartment in human nonfibrotic and fibrotic livers
(
- Contribution to journal › Article
- 2016
-
Mark
Pregnancy and childbirth in women with autoimmune hepatitis is safe, even in compensated cirrhosis.
(
- Contribution to journal › Article
- 2015
-
Mark
Hepatocellular and extrahepatic cancer in patients with autoimmune hepatitis - a long-term follow-up study in 634 Swedish patients
(
- Contribution to journal › Article